Keywords: Neurofluids, DSC & DCE Perfusion, Alzheimer' Disease; CSF clearance; GBCA
Motivation: Accumulation of abnormal proteins in AD has been linked with barrier breakdown between blood and tissue or CSF, and impaired clearance from the brain.
Goal(s): To use GBCA-induced signal changes in ventricular CSF following intravenous injection and its decay over time as indices to study the integrity of blood-CSF barrier (BCSFB) and GBCA clearance via CSF, respectively.
Approach: Dynamic-susceptibility-contrast-in-the-CSF (cDSC) MRI was performed in the 3xTg-AD mouse model.
Results: Impaired clearance in AD mice became significant at 8 months. The amount of GBCA crossing BCSFB appeared similar between AD and WT mice at these early stages.
Impact: Our results suggest that delayed CSF clearance may provide a more sensitive marker for AD, and parameters measured during the clearance phase may be more robust than measures obtained immediately after GBCA administration.
How to access this content:
For one year after publication, abstracts and videos are only open to registrants of this annual meeting. Registrants should use their existing login information. Non-registrant access can be purchased via the ISMRM E-Library.
After one year, current ISMRM & ISMRT members get free access to both the abstracts and videos. Non-members and non-registrants must purchase access via the ISMRM E-Library.
After two years, the meeting proceedings (abstracts) are opened to the public and require no login information. Videos remain behind password for access by members, registrants and E-Library customers.
Keywords